EGEIRO PHARMA

Open bankruptcy

Public limited companyfounded 2017Avenue Jean Mermoz 32, 6041 Charleroi, BelgiumKBO/BCE: BE 0684.906.013

Follow Report

EGEIRO PHARMAOpen bankruptcy

Report

Acts, filings and financial milestones

All 28Signals 1Financial 4Gazette 17Filings 6

2025

21-03

Bankruptcy Bankruptcy declared

Enterprise Court of Hainaut, Charleroi division · judgment of 17-03-2025

2024

20-12

Gazette deed Amendment of the articles

Correction · Capital5 points ▸

Correction, 356917.5, “Article 5” (deed in French)
General meeting, 28-10-2024
Correction, 12221324.28, EUR, mentioned 2 times in the deed
Capital, €12,221,324.28
Other provision, “délivrance de l’extrait avant enregistrement, article 173,1° bis du Code des Droits d'Enregistrement” (deed in French)

Open the act in the Belgian Official Gazette

17-12

Gazette deed Capital increase of €33,138.20 to €12,254,462.48

Financial instrument7 points ▸

Other provision, “représentation à l’acte, conseil d’administration” (deed in French)
Financial instrument, subscription, “Conseil d’Administration” (deed in French)
Financial instrument, 15, “conversion” (deed in French)
Other provision, “conservation du relevé des conversions, dossier du notaire soussigné” (deed in French)
Capital increase, €33,138.20
Capital, €12,254,462.48
Other provision, “délivrance de l’extrait avant enregistrement, article 173,1° bis du Code des Droits d'Enregistrement” (deed in French)

Open the act in the Belgian Official Gazette

13-12

Gazette deed 1 director appointed, 2 directors resigning

Resignations: ENRICO BASTIANELLI SRL (director) and Catherine BUR (daily management delegate) · Appointment: Gaëtan TERRASSE (daily management delegate)4 points ▸

Board meeting, 18-11-2024
Director resignation, ENRICO BASTIANELLI SRL (director)
Director resignation, Catherine BUR (daily management delegate)
Director appointment, Gaëtan TERRASSE (daily management delegate)

Open the act in the Belgian Official Gazette

22-11

Gazette deed Resignation: ENRICO BASTIANELLI SRL (daily management delegate)

Appointment: Catherine BUR (daily management delegate) · Director discharge4 points ▸

Board meeting, 01-11-2024
Director resignation, ENRICO BASTIANELLI SRL (daily management delegate)
Director discharge, ENRICO BASTIANELLI SRL
Director appointment, Catherine BUR (daily management delegate)

Open the act in the Belgian Official Gazette

12-11

Gazette deed Company renamed from TheraVet to EGEIRO PHARMA

Capital increase of €11,864,406.78 to €12,221,324.28 · Resignations: Simon Wheeler, Nesya Goris LifeSciences Consulting and 2 others · Appointments: TERRASSE Gaëtan, BUR Catherine Suzanne Madeleine and 2 others24 points ▸

General meeting, 28-10-2024
Other provision, “prise de connaissance des rapports dans le cadre de l’augmentation du capital en nature, TROISIÈME RÉSOLUTION” (deed in French)
Auditor report, EUR, “no fairness opinion:ne se prononce pas sur caractère approprié,évaluation de la rémunération,caractère légitime et équitable” (deed in French)
Capital increase, €11,864,406.78
Amendment of the articles, 5
Authorised capital, “nouvelle version article 6 et rapport spécial art.7:199 CSA, octroi” (deed in French)
Amendment of the articles, 6
Director resignation, Simon Wheeler (director)
Director resignation, Nesya Goris LifeSciences Consulting (director)
Director resignation, ENRICO BASTIANELLI (director)
Director resignation, Fataki (director)
Director appointment, TERRASSE Gaëtan (director)
The act holds 12 more points.

Open the act in the Belgian Official Gazette

18-09

Gazette deed Capital increase of €15,495.80 to €356,917.50

Financial instrument · Amendment of the articles7 points ▸

Other provision, “période de souscription des obligations convertibles, Conseil d’administration” (deed in French)
Financial instrument, 12, “conversion” (deed in French)
Other provision, “dossier du notaire soussigné, conservation du relevé” (deed in French)
Share issue, “conversion des obligations convertibles susmentionnées, actions ordinaires” (deed in French)
Capital increase, €15,495.80
Amendment of the articles, 5
Other provision, “délivrance avant enregistrement, article 173,1° bis du Code des Droits d’Enregistrement” (deed in French)

Open the act in the Belgian Official Gazette

06-09

Gazette deed Capital increase of €19,028.10 to €341,421.70

Financial instrument5 points ▸

Financial instrument, 42, “conversion” (deed in French)
Capital increase, €19,028.10
Other provision, “prime d'émission”, 85971.9 (deed in French)
Capital, €341,421.70
Other provision, “délivrance avant enregistrement, article 173,1° bis du Code des Droits d'Enregistrement” (deed in French)

Open the act in the Belgian Official Gazette

08-08

NBB filing Annual accounts 2023 filedPDF

full format · 8 days late

18-07

Gazette deed 1 director appointed, 2 reappointed

Appointment: FATAKI BV (director) · Permanent representatives: Johan Dreesen and Enrico Bastianelli · Reappointments: FATAKI BV (director) and ENRICO BASTIANELLI SRL (director)10 points ▸

General meeting, 06-06-2024
Director appointment, FATAKI BV (director)
Permanent representative, Johan Dreesen (representative)
Director reappointment, FATAKI BV (director)
Director reappointment, ENRICO BASTIANELLI SRL (director)
Permanent representative, Enrico Bastianelli (representative)
Board composition, Simon Wheeler (chair)
Board composition, NESYA GORIS LIFESCIENCES CONSULTING BV (director)
Board composition, ENRICO BASTIANELLI SRL (director)
Board composition, FATAKI BV (director)

Open the act in the Belgian Official Gazette

2023

05-12

Gazette deed Miscellaneous

Financial instrument · Capital increase · Power of attorney8 points ▸

Board meeting, 20-11-2023
Other provision, “prise de connaissance des rapports” (deed in French)
Other provision, “suppression du droit de préférence, émission des obligations convertibles” (deed in French)
Financial instrument, “nominatives, conditions et modalités approuvées selon rapport du conseil d’administration(Annexe 2)” (deed in French)
Financial instrument, 80, “souscription” (deed in French)
Capital increase
Power of attorney
Other provision, “extrait délivré avant enregistrement, article 173,1°bis du Code des Droits d’Enregistrement” (deed in French)

Open the act in the Belgian Official Gazette

23-11

Gazette deed Resignations: Julie WINAND (director) and CAPITAL & CROISSANCE SCRL (director)

6 points ▸

Board meeting, 05-09-2023
Director resignation, Julie WINAND (director)
Director resignation, CAPITAL & CROISSANCE SCRL (director)
Board composition, Simon WHEELER (director)
Board composition, NESYA GORIS LIFESCIENCES CONSULTING BVBA (director)
Board composition, ENRICO BASTIANELLI SRL (director)

Open the act in the Belgian Official Gazette

Show earlier events

20-06

Gazette deed Appointment: PwC Réviseurs d'Entreprises SRL (représentant du commissaire)

2 points ▸

General meeting, 01-06-2023
Auditor appointment, PwC Réviseurs d'Entreprises SRL (représentant du commissaire)

Open the act in the Belgian Official Gazette

06-06

NBB filing Annual accounts 2022 filedPDF

full format · 55 days before the deadline

05-01

Gazette deed Resignation: VEL-VET AH CONSULTING SAS (director)

Permanent representatives: Christian SCHIRVEL, Nesya GORIS and 2 others11 points ▸

Board meeting, 21-12-2022
Director resignation, VEL-VET AH CONSULTING SAS (director)
Board composition, Simon WHEELER (director)
Board composition, NESYA GORIS LIFESCIENCES CONSULTING BVBA (director)
Board composition, CAPITAL & CROISSANCE SCRL (director)
Board composition, ENRICO BASTIANELLI SRL (director)
Board composition, Julie WINAND (director)
Permanent representative, Christian SCHIRVEL (representative)
Permanent representative, Nesya GORIS (representative)
Permanent representative, Jean-Philippe MATHIEU (representative)
Permanent representative, Enrico BASTIANELLI (representative)

Open the act in the Belgian Official Gazette

2022

31-12

Financial Weakest financial yearnet -€2.3m

The net result drops to -€2.3m, the lowest from 2018 to 2023.

10-11

Gazette deed Permanent representatives: Mélanie Adorante and Patrick Mortroux

4 points ▸

Permanent representative, Mélanie Adorante (représentant pour l'exercice du mandat de commissaire)
Permanent representative, Patrick Mortroux (représentant pour l'exercice du mandat de commissaire)
Other provision, “commissaire, mandat de commissaire” (deed in French)
Other provision, “Administrateur, représentation pour extrait conforme” (deed in French)

Open the act in the Belgian Official Gazette

28-06

NBB filing Annual accounts 2021 filedPDF

full format · 33 days before the deadline

23-06

Gazette deed 1 director appointed, 2 reappointed

Reappointments: NESYA GORIS LIFESCIENCES CONSULTING BV, Simon Wheeler and SC PwC Réviseurs d'Entreprises · Appointment: Vel-Vet AH Consulting SAS (director)5 points ▸

General meeting, 02-06-2022
Director reappointment, NESYA GORIS LIFESCIENCES CONSULTING BV (director)
Director reappointment, Simon Wheeler (director)
Director appointment, Vel-Vet AH Consulting SAS (director)
Auditor reappointment, SC PwC Réviseurs d'Entreprises (statutory auditor)

Open the act in the Belgian Official Gazette

22-02

Gazette deed 3 directors appointed, 1 director resigning

Appointments: Nesya Goris LifeSciences Consulting BV (director) and Simon Wheeler (director) · Permanent representatives: André Ostachkov, Nesya Goris and 2 others · Resignation: EEBIC Ventures SA (director)12 points ▸

Board meeting, 14-12-2021
Other provision, 21-09-2021, “vacance du poste d'administrateur” (deed in French)
Director appointment, Nesya Goris LifeSciences Consulting BV (director)
Permanent representative, André Ostachkov (representative)
Permanent representative, Nesya Goris (representative)
Other provision, “confirmation de la nomination à l'ordre du jour de la prochaine réunion de l'assemblée générale” (deed in French), mentioned 2 times in the deed
Director resignation, EEBIC Ventures SA (director)
Permanent representative, Mohamed Lotfi Yelles Chaouche (representative)
Director appointment, Simon Wheeler (director)
Director appointment, Simon Wheeler (président du conseil)
Other provision, “observateur au Conseil, nomination d'observateur” (deed in French)
Permanent representative, Christian Schirvel (representative)

Open the act in the Belgian Official Gazette

2021

31-12

Financial Liquidity more than doubledcurrent ratio 6.96

The current ratio rises from 2.32 to 6.96. Short-term debt falls from €1.0m to €884,468.

31-12

Financial Equity above €5mequity €9.6m ▲184%

Equity rises from €3.4m to €9.6m.

30-09

Gazette deed Registered office moved from Jumet to Charleroi

New seat: 6041 Charleroi, Avenue Jean Mermoz 32/1, Bâtiment BIOTECH 3 · Previous seat: Rue d'Edimbourg 11, boite B, 6040 Jumet2 points ▸

Board meeting, 13-09-2021
Registered-office move, 6041 Charleroi,Avenue Jean Mermoz 32/1,Bâtiment BIOTECH 3

Open the act in the Belgian Official Gazette

21-06

NBB filing Annual accounts 2020 filedPDF

full format · 40 days before the deadline

2020

31-12

Financial Equity above €2mequity €3.4m ▲119%

Equity rises from €1.5m to €3.4m.

17-07

NBB filing Annual accounts 2019 filedPDF

micro format · 14 days before the deadline

2019

28-06

NBB filing Annual accounts 2018 filedPDF

micro format · 33 days before the deadline

2017

24-11

Gazette deed IncorporationPDF

25 publications in the Belgian Official Gazette, the last on 20-12-2024

SignalFinancial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official Gazette Filings with the National Bank

History

EGEIRO PHARMA was incorporated on 22 November 2017.¹ The registered office was moved to Charleroi in 2021.² In 2024 the company took the name EGEIRO PHARMA.³ The capital was increased 4 times in 2024, most recently to €12.3m.⁴³⁵ Turnover grew from €12,348 in 2021 to €117,839 in 2023 and headcount from 3.6 full-time equivalents in 2018 to 7.5 in 2023.⁶ On 17 March 2025 the company was declared bankrupt.⁷

Next steps

See who ran this company and where it was based, on a date before it ended.Company as of a date See where the procedure stands, who runs it and what to do with an unpaid invoice from this company.Creditor guide